Breaking News Instant updates and real-time market news.

SPG

Simon Property

$131.60 /

+6.27 (+5.00%)

15:57
06/21/21
06/21
15:57
06/21/21
15:57

Simon Property price target raised to $125 from $120 at Stifel

Stifel analyst Simon Yarmak raised the firm's price target on Simon Property to $125 from $120 and keeps a Hold rating on the shares. The analyst added that he is adjusting his estimates on the shares after the company raised its quarterly dividend, the first dividend raise since the company resized its dividend last June.

  • 19

    Nov

SPG Simon Property
$131.60 /

+6.27 (+5.00%)

06/11/21 Morgan Stanley
Simon Property price target raised to $150 from $140 at Morgan Stanley
06/08/21 Deutsche Bank
Simon Property price target raised to $142 from $120 at Deutsche Bank
06/03/21 UBS
Simon Property initiated with a Neutral at UBS
05/21/21 Piper Sandler
Simon Property price target raised to $150 from $130 at Piper Sandler

TODAY'S FREE FLY STORIES

Earnings
Monster Beverage reports Q2 EPS 75c, consensus 68c » 16:11
08/05/21
08/05
16:11
08/05/21
16:11
MNST

Monster Beverage

$92.01 /

-0.02 (-0.02%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MNST Monster Beverage
$92.01 /

-0.02 (-0.02%)

07/30/21 Deutsche Bank
Monster Beverage price target raised to $108 from $105 at Deutsche Bank
07/23/21
Fly Intel: Top five analyst upgrades
07/23/21 Citi
Monster Beverage upgraded to Buy from Neutral at Citi
06/02/21 Morgan Stanley
Survey increases confidence in Monster Beverage outlook, says Morgan Stanley
MNST Monster Beverage
$92.01 /

-0.02 (-0.02%)

MNST Monster Beverage
$92.01 /

-0.02 (-0.02%)

MNST Monster Beverage
$92.01 /

-0.02 (-0.02%)

MNST Monster Beverage
$92.01 /

-0.02 (-0.02%)

Earnings
GoPro reports Q2 adjusted EPS 12c, consensus 4c » 16:11
08/05/21
08/05
16:11
08/05/21
16:11
GPRO

GoPro

$10.03 /

+0.15 (+1.52%)

Reports Q2 revenue $250M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GPRO GoPro
$10.03 /

+0.15 (+1.52%)

GPRO GoPro
$10.03 /

+0.15 (+1.52%)

02/08/21 Citi
GoPro price target raised to $6 from $3 at Citi
GPRO GoPro
$10.03 /

+0.15 (+1.52%)

GPRO GoPro
$10.03 /

+0.15 (+1.52%)

GPRO GoPro
$10.03 /

+0.15 (+1.52%)

Earnings
iRhythm Sees FY21 revenue $320M-$325M, consensus $302.33M » 16:11
08/05/21
08/05
16:11
08/05/21
16:11
IRTC

iRhythm

$48.28 /

-1.43 (-2.88%)

For FY21, the company…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IRTC iRhythm
$48.28 /

-1.43 (-2.88%)

IRTC iRhythm
$48.28 /

-1.43 (-2.88%)

06/02/21 Citi
iRhythm downgraded to Neutral from Buy at Citi
04/14/21 Morgan Stanley
iRhythm downgraded to Equal Weight from Overweight at Morgan Stanley
04/13/21 Truist
iRhythm price target lowered to $115 from $220 at Truist
04/13/21 BTIG
iRhythm downgraded to Neutral from Buy at BTIG
IRTC iRhythm
$48.28 /

-1.43 (-2.88%)

  • 10
    Jun
  • 19
    Aug
IRTC iRhythm
$48.28 /

-1.43 (-2.88%)

IRTC iRhythm
$48.28 /

-1.43 (-2.88%)

Hot Stocks
Zynga to acquire StarLark for $525M in cash, stock » 16:11
08/05/21
08/05
16:11
08/05/21
16:11
ZNGA

Zynga

$9.78 /

-0.105 (-1.06%)

Zynga announced it has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ZNGA Zynga
$9.78 /

-0.105 (-1.06%)

ZNGA Zynga
$9.78 /

-0.105 (-1.06%)

06/30/21 Morgan Stanley
Morgan Stanley double downgrades overvalued AppLovin to Underweight
05/06/21
Fly Intel: Top five analyst upgrades
05/06/21 BofA
Zynga upgraded to Buy from Neutral at BofA
05/06/21 BofA
Zynga upgraded to Buy from Neutral at BofA
ZNGA Zynga
$9.78 /

-0.105 (-1.06%)

  • 07
    Aug
ZNGA Zynga
$9.78 /

-0.105 (-1.06%)

ZNGA Zynga
$9.78 /

-0.105 (-1.06%)

ZNGA Zynga
$9.78 /

-0.105 (-1.06%)

Earnings
Redfin reports Q2 EPS (29c), consensus (33c) » 16:11
08/05/21
08/05
16:11
08/05/21
16:11
RDFN

Redfin

$60.75 /

+1.53 (+2.58%)

Reports Q2 revenue $471M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RDFN Redfin
$60.75 /

+1.53 (+2.58%)

RDFN Redfin
$60.75 /

+1.53 (+2.58%)

07/21/21 Berenberg
Redfin initiated with a Hold at Berenberg
06/03/21
Fly Intel: Top five analyst upgrades
06/03/21 Stephens
Redfin upgraded to Overweight from Equal Weight at Stephens
05/26/21 RBC Capital
Redfin assumed with an Outperform at RBC Capital
RDFN Redfin
$60.75 /

+1.53 (+2.58%)

RDFN Redfin
$60.75 /

+1.53 (+2.58%)

RDFN Redfin
$60.75 /

+1.53 (+2.58%)

RDFN Redfin
$60.75 /

+1.53 (+2.58%)

Earnings
Cognex reports Q2 EPS 43c, consensus 42c » 16:11
08/05/21
08/05
16:11
08/05/21
16:11
CGNX

Cognex

$91.24 /

+0.96 (+1.06%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CGNX Cognex
$91.24 /

+0.96 (+1.06%)

CGNX Cognex
$91.24 /

+0.96 (+1.06%)

05/19/21 Raymond James
Cognex upgraded to Strong Buy from Outperform at Raymond James
05/19/21 Raymond James
Cognex upgraded to Strong Buy from Outperform at Raymond James
02/12/21 Cowen
Cognex price target raised to $105 from $85 at Cowen
01/14/21 HSBC
Cognex upgraded to Buy from Hold at HSBC
CGNX Cognex
$91.24 /

+0.96 (+1.06%)

CGNX Cognex
$91.24 /

+0.96 (+1.06%)

Earnings
Motorola Solutions reports Q2 EPS $2.07, consensus $1.92 » 16:11
08/05/21
08/05
16:11
08/05/21
16:11
MSI

Motorola Solutions

$222.46 /

-0.26 (-0.12%)

Reports Q2 revenue $2.0B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MSI Motorola Solutions
$222.46 /

-0.26 (-0.12%)

MSI Motorola Solutions
$222.46 /

-0.26 (-0.12%)

07/15/21 Northcoast
Motorola Solutions price target raised to $244 from $215 at Northcoast
07/09/21 Jefferies
UK Airwave probe of Motorola Solutions a 'red herring' says Jefferies
07/06/21 Jefferies
Motorola Solutions price target raised to $260 from $230 at Jefferies
07/06/21 Morgan Stanley
Motorola Solutions price target raised to $230 from $210 at Morgan Stanley
MSI Motorola Solutions
$222.46 /

-0.26 (-0.12%)

Earnings
Illumina reports Q2 adjusted EPS $1.87, consensus $1.35 » 16:11
08/05/21
08/05
16:11
08/05/21
16:11
ILMN

Illumina

$514.52 /

+9.92 (+1.97%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ILMN Illumina
$514.52 /

+9.92 (+1.97%)

ILMN Illumina
$514.52 /

+9.92 (+1.97%)

07/13/21 Barclays
Illumina price target raised to $355 from $300 at Barclays
06/01/21 Evercore ISI
Evercore ISI upgrades Illumina to In Line on base business turnaround
06/01/21 Evercore ISI
Illumina upgraded to In Line from Underperform at Evercore ISI
04/28/21 Wells Fargo
Illumina price target raised to $340 from $330 at Wells Fargo
ILMN Illumina
$514.52 /

+9.92 (+1.97%)

ILMN Illumina
$514.52 /

+9.92 (+1.97%)

ILMN Illumina
$514.52 /

+9.92 (+1.97%)

ILMN Illumina
$514.52 /

+9.92 (+1.97%)

Hot Stocks
Zynga's Rollic reports 1B game downloads worldwide » 16:10
08/05/21
08/05
16:10
08/05/21
16:10
ZNGA

Zynga

$9.78 /

-0.105 (-1.06%)

Zynga subsidiary Rollic…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ZNGA Zynga
$9.78 /

-0.105 (-1.06%)

ZNGA Zynga
$9.78 /

-0.105 (-1.06%)

06/30/21 Morgan Stanley
Morgan Stanley double downgrades overvalued AppLovin to Underweight
05/06/21
Fly Intel: Top five analyst upgrades
05/06/21 BofA
Zynga upgraded to Buy from Neutral at BofA
05/06/21 BofA
Zynga upgraded to Buy from Neutral at BofA
ZNGA Zynga
$9.78 /

-0.105 (-1.06%)

  • 07
    Aug
ZNGA Zynga
$9.78 /

-0.105 (-1.06%)

ZNGA Zynga
$9.78 /

-0.105 (-1.06%)

ZNGA Zynga
$9.78 /

-0.105 (-1.06%)

Earnings
Beyond Meat sees Q3 revenue $120M-$140M, consensus $153.7M » 16:10
08/05/21
08/05
16:10
08/05/21
16:10
BYND

Beyond Meat

$122.41 /

-0.36 (-0.29%)

Beyond Meat said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BYND Beyond Meat
$122.41 /

-0.36 (-0.29%)

BYND Beyond Meat
$122.41 /

-0.36 (-0.29%)

07/28/21 Piper Sandler
Synthetic biology a threat to Beyond Meat's 'ambition,' says Piper Sandler
06/23/21 JPMorgan
Beyond Meat breakfast sandwich discontinued at Dunkin', says JPMorgan
05/24/21
Fly Intel: Top five analyst upgrades
05/24/21 Bernstein
Beyond Meat upgraded to Outperform from Underperform at Bernstein
BYND Beyond Meat
$122.41 /

-0.36 (-0.29%)

BYND Beyond Meat
$122.41 /

-0.36 (-0.29%)

BYND Beyond Meat
$122.41 /

-0.36 (-0.29%)

BYND Beyond Meat
$122.41 /

-0.36 (-0.29%)

Earnings
Enanta reports Q3 EPS ($1.19), consensus ($1.26) » 16:10
08/05/21
08/05
16:10
08/05/21
16:10
ENTA

Enanta

$44.22 /

+1.59 (+3.73%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ENTA Enanta
$44.22 /

+1.59 (+3.73%)

ENTA Enanta
$44.22 /

+1.59 (+3.73%)

02/09/21 RBC Capital
Enanta price target raised to $53 from $47 at RBC Capital
01/29/21 JPMorgan
Enanta upgraded to Neutral with $55 target at JPMorgan
01/29/21 JPMorgan
Enanta upgraded to Neutral from Underweight at JPMorgan
01/08/21 Piper Sandler
Enanta remains 'significantly undervalued,' says Piper Sandler
ENTA Enanta
$44.22 /

+1.59 (+3.73%)

Hot Stocks
Novavax on track to achieve 100M dose monthly capacity by end of Q3 » 16:10
08/05/21
08/05
16:10
08/05/21
16:10
NVAX

Novavax

$236.00 /

+12.2 (+5.45%)

On track to achieve 100…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NVAX Novavax
$236.00 /

+12.2 (+5.45%)

NVAX Novavax
$236.00 /

+12.2 (+5.45%)

08/04/21 Cantor Fitzgerald
Novavax EU deal suggests bottlenecks have been resolved, says Cantor Fitzgerald
06/15/21 Cantor Fitzgerald
Novavax price target raised to $272 from $217 at Cantor Fitzgerald
06/07/21 B. Riley
Novavax risk/reward attractive into Covid vaccine data, says B. Riley
05/12/21
Fly Intel: Top five analyst downgrades
NVAX Novavax
$236.00 /

+12.2 (+5.45%)

NVAX Novavax
$236.00 /

+12.2 (+5.45%)

NVAX Novavax
$236.00 /

+12.2 (+5.45%)

NVAX Novavax
$236.00 /

+12.2 (+5.45%)

Earnings
Gritstone reports Q2 EPS (33c), consensus (58c) » 16:10
08/05/21
08/05
16:10
08/05/21
16:10
GRTS

Gritstone

$6.93 /

+0.51 (+7.94%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GRTS Gritstone
$6.93 /

+0.51 (+7.94%)

GRTS Gritstone
$6.93 /

+0.51 (+7.94%)

01/21/21 BTIG
Gritstone Oncology price target raised to $35 from $17 at BTIG
01/20/21 H.C. Wainwright
Gritstone Oncology price target raised to $24 from $16 at H.C. Wainwright
01/20/21 Baird
Gritstone Oncology downgraded to Underperform from Outperform at Baird
GRTS Gritstone
$6.93 /

+0.51 (+7.94%)

Earnings
iRhythm reports Q2 EPS (59c), consensus (94c) » 16:09
08/05/21
08/05
16:09
08/05/21
16:09
IRTC

iRhythm

$48.25 /

-1.46 (-2.94%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IRTC iRhythm
$48.25 /

-1.46 (-2.94%)

IRTC iRhythm
$48.25 /

-1.46 (-2.94%)

06/02/21 Citi
iRhythm downgraded to Neutral from Buy at Citi
04/14/21 Morgan Stanley
iRhythm downgraded to Equal Weight from Overweight at Morgan Stanley
04/13/21 Truist
iRhythm price target lowered to $115 from $220 at Truist
04/13/21 BTIG
iRhythm downgraded to Neutral from Buy at BTIG
IRTC iRhythm
$48.25 /

-1.46 (-2.94%)

  • 10
    Jun
  • 19
    Aug
IRTC iRhythm
$48.25 /

-1.46 (-2.94%)

IRTC iRhythm
$48.25 /

-1.46 (-2.94%)

Earnings
Novavax reports Q2 EPS ($4.75), consensus ($3.63) » 16:09
08/05/21
08/05
16:09
08/05/21
16:09
NVAX

Novavax

$236.11 /

+12.31 (+5.50%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NVAX Novavax
$236.11 /

+12.31 (+5.50%)

NVAX Novavax
$236.11 /

+12.31 (+5.50%)

08/04/21 Cantor Fitzgerald
Novavax EU deal suggests bottlenecks have been resolved, says Cantor Fitzgerald
06/15/21 Cantor Fitzgerald
Novavax price target raised to $272 from $217 at Cantor Fitzgerald
06/07/21 B. Riley
Novavax risk/reward attractive into Covid vaccine data, says B. Riley
05/12/21
Fly Intel: Top five analyst downgrades
NVAX Novavax
$236.11 /

+12.31 (+5.50%)

NVAX Novavax
$236.11 /

+12.31 (+5.50%)

NVAX Novavax
$236.11 /

+12.31 (+5.50%)

NVAX Novavax
$236.11 /

+12.31 (+5.50%)

Earnings
Spero Therapeutics reports Q2 EPS (63c), consensus (77c) » 16:09
08/05/21
08/05
16:09
08/05/21
16:09
SPRO

Spero Therapeutics

$14.11 /

+0.52 (+3.83%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SPRO Spero Therapeutics
$14.11 /

+0.52 (+3.83%)

SPRO Spero Therapeutics
$14.11 /

+0.52 (+3.83%)

01/22/21 H.C. Wainwright
Spero Therapeutics price target raised to $40 from $33 at H.C. Wainwright
12/16/20 Berenberg
Berenberg starts 'greatly underappreciated' Spero with Buy rating
12/16/20 Berenberg
Spero Therapeutics initiated with a Buy at Berenberg
11/23/20 H.C. Wainwright
Spero Therapeutics price target raised to $33 from $28 at H.C. Wainwright
SPRO Spero Therapeutics
$14.11 /

+0.52 (+3.83%)

  • 11
    Sep
SPRO Spero Therapeutics
$14.11 /

+0.52 (+3.83%)

Earnings
Universal Display backs FY21 revenue view $530M-$560M, consensus $559.1M  16:09
08/05/21
08/05
16:09
08/05/21
16:09
OLED

Universal Display

$233.53 /

+1.87 (+0.81%)

 
ShowHide Related Items >><<
OLED Universal Display
$233.53 /

+1.87 (+0.81%)

OLED Universal Display
$233.53 /

+1.87 (+0.81%)

05/19/21 Citi
Universal Display upgraded to Buy from Neutral at Citi
05/19/21 Citi
Universal Display upgraded to Buy from Neutral at Citi
03/08/21 Evercore ISI
Evercore ISI 'emphatically' reiterates Outperform rating on Universal Display
03/08/21 Roth Capital
Universal Display upgraded to Buy at Roth Capital
OLED Universal Display
$233.53 /

+1.87 (+0.81%)

Earnings
Beyond Meat reports Q2 EPS (31c), consensus (23c) » 16:09
08/05/21
08/05
16:09
08/05/21
16:09
BYND

Beyond Meat

$122.62 /

-0.15 (-0.12%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BYND Beyond Meat
$122.62 /

-0.15 (-0.12%)

BYND Beyond Meat
$122.62 /

-0.15 (-0.12%)

07/28/21 Piper Sandler
Synthetic biology a threat to Beyond Meat's 'ambition,' says Piper Sandler
06/23/21 JPMorgan
Beyond Meat breakfast sandwich discontinued at Dunkin', says JPMorgan
05/24/21
Fly Intel: Top five analyst upgrades
05/24/21 Bernstein
Beyond Meat upgraded to Outperform from Underperform at Bernstein
BYND Beyond Meat
$122.62 /

-0.15 (-0.12%)

BYND Beyond Meat
$122.62 /

-0.15 (-0.12%)

BYND Beyond Meat
$122.62 /

-0.15 (-0.12%)

BYND Beyond Meat
$122.62 /

-0.15 (-0.12%)

Earnings
Catalyst Bancorp reports Q2 adjusted EPS (21c), consensus (19c) » 16:09
08/05/21
08/05
16:09
08/05/21
16:09
CLST

Catalyst Bancorp

/

+

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Earnings
Universal Display reports Q2 EPS $1.94, consensus 87c » 16:09
08/05/21
08/05
16:09
08/05/21
16:09
OLED

Universal Display

$233.53 /

+1.87 (+0.81%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OLED Universal Display
$233.53 /

+1.87 (+0.81%)

OLED Universal Display
$233.53 /

+1.87 (+0.81%)

05/19/21 Citi
Universal Display upgraded to Buy from Neutral at Citi
05/19/21 Citi
Universal Display upgraded to Buy from Neutral at Citi
03/08/21 Evercore ISI
Evercore ISI 'emphatically' reiterates Outperform rating on Universal Display
03/08/21 Roth Capital
Universal Display upgraded to Buy at Roth Capital
OLED Universal Display
$233.53 /

+1.87 (+0.81%)

Hot Stocks
Novavax: Covid vaccine data shows increase in neutralizing antibody levels » 16:09
08/05/21
08/05
16:09
08/05/21
16:09
NVAX

Novavax

$236.50 /

+12.7 (+5.67%)

Novavax announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NVAX Novavax
$236.50 /

+12.7 (+5.67%)

NVAX Novavax
$236.50 /

+12.7 (+5.67%)

08/04/21 Cantor Fitzgerald
Novavax EU deal suggests bottlenecks have been resolved, says Cantor Fitzgerald
06/15/21 Cantor Fitzgerald
Novavax price target raised to $272 from $217 at Cantor Fitzgerald
06/07/21 B. Riley
Novavax risk/reward attractive into Covid vaccine data, says B. Riley
05/12/21
Fly Intel: Top five analyst downgrades
NVAX Novavax
$236.50 /

+12.7 (+5.67%)

NVAX Novavax
$236.50 /

+12.7 (+5.67%)

NVAX Novavax
$236.50 /

+12.7 (+5.67%)

NVAX Novavax
$236.50 /

+12.7 (+5.67%)

Earnings
Outset Medical reports Q2 EPS (57c), consensus (69c) » 16:08
08/05/21
08/05
16:08
08/05/21
16:08
OM

Outset Medical

$39.42 /

-1.48 (-3.62%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OM Outset Medical
$39.42 /

-1.48 (-3.62%)

OM Outset Medical
$39.42 /

-1.48 (-3.62%)

07/02/21 Stifel
Outset Medical CFO departure 'unexpected and surprising,' says Stifel
04/19/21 Wells Fargo
Outset Medical initiated with an Overweight at Wells Fargo
12/15/20 Oppenheimer
Oppenheimer starts Outset Medical at Perform, citing competition
12/15/20 Oppenheimer
Outset Medical initiated with a Perform at Oppenheimer
OM Outset Medical
$39.42 /

-1.48 (-3.62%)

  • 09
    Apr
  • 03
    Dec
  • 15
    Sep
OM Outset Medical
$39.42 /

-1.48 (-3.62%)

Earnings
Puma Biotechnology reports Q2 adjusted EPS 32c, consensus (34c) » 16:08
08/05/21
08/05
16:08
08/05/21
16:08
PBYI

Puma Biotechnology

$6.99 /

+0.13 (+1.90%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PBYI Puma Biotechnology
$6.99 /

+0.13 (+1.90%)

PBYI Puma Biotechnology
$6.99 /

+0.13 (+1.90%)

12/24/20 Craig-Hallum
Celcuity price target raised to $19 from $16 at Craig-Hallum
PBYI Puma Biotechnology
$6.99 /

+0.13 (+1.90%)

Hot Stocks
Novavax, Serum Institute of India announce submission to regulators for vaccine » 16:08
08/05/21
08/05
16:08
08/05/21
16:08
NVAX

Novavax

$236.77 /

+12.97 (+5.80%)

Novavax, with its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NVAX Novavax
$236.77 /

+12.97 (+5.80%)

NVAX Novavax
$236.77 /

+12.97 (+5.80%)

08/04/21 Cantor Fitzgerald
Novavax EU deal suggests bottlenecks have been resolved, says Cantor Fitzgerald
06/15/21 Cantor Fitzgerald
Novavax price target raised to $272 from $217 at Cantor Fitzgerald
06/07/21 B. Riley
Novavax risk/reward attractive into Covid vaccine data, says B. Riley
05/12/21
Fly Intel: Top five analyst downgrades
NVAX Novavax
$236.77 /

+12.97 (+5.80%)

NVAX Novavax
$236.77 /

+12.97 (+5.80%)

NVAX Novavax
$236.77 /

+12.97 (+5.80%)

NVAX Novavax
$236.77 /

+12.97 (+5.80%)

Hot Stocks
Outset Medical names Nabeel Ahmed as new CFO » 16:07
08/05/21
08/05
16:07
08/05/21
16:07
OM

Outset Medical

$39.39 /

-1.51 (-3.69%)

Outset Medical announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OM Outset Medical
$39.39 /

-1.51 (-3.69%)

OM Outset Medical
$39.39 /

-1.51 (-3.69%)

07/02/21 Stifel
Outset Medical CFO departure 'unexpected and surprising,' says Stifel
04/19/21 Wells Fargo
Outset Medical initiated with an Overweight at Wells Fargo
12/15/20 Oppenheimer
Oppenheimer starts Outset Medical at Perform, citing competition
12/15/20 Oppenheimer
Outset Medical initiated with a Perform at Oppenheimer
OM Outset Medical
$39.39 /

-1.51 (-3.69%)

  • 09
    Apr
  • 03
    Dec
  • 15
    Sep
OM Outset Medical
$39.39 /

-1.51 (-3.69%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.